Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-04 Sale |
2024-03-04 6:12 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
3,934 | $41.86 | $164,664 | 329,851 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 4:34 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
400 | $45 | $18,000 | 137,192 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 6:46 pm |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $39.05 | $195,258 | 37,083 (Direct) |
View |
| 2024-02-09 Sale |
2024-02-09 7:47 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
46,137 | $35.5 | $1,638,071 | 137,592 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 7:37 pm |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $30.05 | $300,470 | 21,349 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 5:15 pm |
Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer |
3,295 | $22.58 | $74,416 | 34,205 (Direct) |
View |
| 2023-11-02 Purchase |
2023-11-06 6:07 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
414,105 | $12.8 | $5,301,325 | 378,822 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:31 pm |
Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer |
714 | $31 | $22,132 | 82,324 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
1,298 | $31 | $40,233 | 187,209 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
1,370 | $31 | $42,465 | 247,068 (Direct) |
View |
| 2023-01-11 Purchase |
2023-01-13 5:08 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
41,007 | $30.51 | $1,251,191 | 2,218,295 (Indirect Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 4:53 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
126,474 | $30.22 | $3,821,739 | 890,148 (Indirect) |
View |
| 2023-01-11 Sale |
2023-01-13 4:50 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
126,474 | $30.22 | $3,821,739 | 5,858,262 (Indirect Direct) |
View |
| 2022-12-14 Sale |
2022-12-16 5:05 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
382,244 | $31.36 | $11,985,954 | 917,811 (Indirect) |
View |
| 2022-12-14 Sale |
2022-12-16 5:03 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
382,244 | $31.36 | $11,985,954 | 5,984,736 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-04 4:31 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
220,016 | $30.01 | $6,602,952 | 1,001,417 (Indirect) |
View |
| 2022-11-02 Sale |
2022-11-04 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
220,016 | $30.01 | $6,602,952 | 6,366,980 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-04 6:15 pm |
N/A 2034-02-28 |
Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer |
152,286 | $0 | 186,491 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 6:12 pm |
N/A 2034-02-28 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
530,000 | $0 | 530,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 6:12 pm |
N/A 2034-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
218,750 | $0 | 329,851 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:34 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
400 | $0 | 137,192 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:34 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
400 | $2.08 | 137,192 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-21 6:46 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $0 | 37,083 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-21 6:46 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $10.34 | 37,083 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-09 7:47 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
46,137 | $0 | 137,592 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-09 7:47 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
46,137 | $2.08 | 137,592 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-23 7:37 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $0 | 21,349 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-23 7:37 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $10.34 | 21,349 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-02 5:43 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
9,000 | $0 | 1,135,542 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-02 5:43 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
9,000 | $2.08 | 1,135,542 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 6:00 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
20,000 | $0 | 1,135,542 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 6:00 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
20,000 | $2.08 | 1,135,542 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-08 4:30 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,000 | $0 | 588,938 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-08 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,000 | $2.08 | 588,938 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:55 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
12,000 | $0 | 4,724,983 (Indirect) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:16 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Sandor Victor Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 2:17 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 244,934 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 2:17 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 244,934 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-22 7:35 pm |
N/A 2023-05-22 |
Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer |
233,333 | $0 | 233,333 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:31 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:31 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer |
73,895 | $0 | 82,324 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:30 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
131,250 | $0 | 187,209 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:30 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
166,250 | $0 | 247,068 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:35 pm |
N/A 2033-01-02 |
Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer |
262,500 | $0 | 262,500 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-08 6:11 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
10,000 | $0 | 592,425 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-08 6:11 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
10,000 | $2.08 | 592,425 (Direct) |
View |